Potent New Mechanism of Action for Treatment of Inflammatory Bowel Disease Revealed
Medicine, Health Care Potent New Mechanism of Action… Published: May 28, 2018.Released by University of Tsukuba Tsukuba – Professor Akiyoshi Fukamizu’s research group of Life Science Center for Survival Dynamics (Tsukuba Advanced Research Alliance, TARA), University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai’s in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin
Read More